PORADOSU ENRIQUE (Chief Science and Business Off) purchased 0.1% of their position (2K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $10.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/20/2024ACC: 0001104659-24-120876
Officer· Chief Science and Business Off
Since Feb 2022
+2K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
$4.99
Trade value
$9.98K
% of position
0.1%
11/19/2024
1.50M→1.51M
Total
Net shares
+2K
Net value
$9.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2024 | P · Purchase | +2K | $4.99 | $9.98K | 0.1% | 1.50M | 1.51M |
| Total | +2K | $9.98K | ||||||
Derivative Transactions0
No derivative transactions reported